WEIKANG BIO-TECHNOLOGY GROUP CO., INC. - FORM 10-K - EX-23.2 - EXHIBIT 23.2 - March 31, 2010

Attached files

file filename
10-K - WEIKANG 10-K 12.31.09 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.form10-k.htm
EX-31.1 - EXHIBIT 31.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.ex31_1.htm
EX-31.2 - EXHIBIT 31.2 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.ex31_2.htm
EX-32.1 - EXHIBIT 32.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.ex32_1.htm
EX-23.1 - EXHIBIT 23.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.ex23_1.htm
EX-32.2 - EXHIBIT 32.2 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC.ex32_2.htm

 

 
Exhibit 23.2
 

 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 

 

 
 
We hereby consent to incorporate by reference in the Registration Statement on Form S-8 of our report dated March 31, 2010 relating to the financial statements of Weikang Bio-technology Group Co., Inc., and Subsidiaries (the "Company") for the years ended December 31, 2009 and 2008 which appear in the Company's Current Report on Form 10-K  filed with the SEC on  March 31, 2010. 
 
 
 
 
 
Goldman Parks Kurland Mohidin LLP
 
 
Encino, California
 
 
March 31, 2010
 

 

 

WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Reports